first large study of glp 1 receptor agonists during pregnancy GLP-1 in - What Physicians Need to Know? GLP-1 medications like Ozempic, Wegovy
Description
Rouette J, Yin H, Yu OHY, Bouganim N, Platt RW, Azoulay L
This is important especially in the pediatric population, to have close follow-up with dietitian
Abstract Glucagon-like peptide 1 receptor agonists (GLP-1RAs) have emerged as promising therapeutic agents with potent anti-inflammatory properties and diverse clinical implications
Patients typically begin at a lower dose and increase gradually every four weeks to minimize gastrointestinal side effects and maximize tolerability
Statistics Statistical analysis was performed using SPSS 26.0 (SPSS Inc, Chicago, IL, USA)
